Coverage
-
April 02, 2018
A Delaware federal judge on Saturday refused to grant Nova Biomedical Corp. attorneys' fees for beating Roche Diagnostics Operations Inc.'s patent infringement litigation over glucose monitoring technology, but also refused Roche fees for defeating Nova's subsequent breach of contract counterclaims.
3 other articles on this case.
View all »